The power of CRISPR became definitively clear when the first CRISPR-based gene therapy, Casgevy (exa-cel), won regulatory approvals for the treatment of sickle cell disease. But CRISPR’s applications ...
The Medical Working Group of the open machine learning consortium MLCommons today announced the availability of a new and open benchmarking platform called MedPerf. MedPerf is a big deal, the group ...
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World Data Endometrial cancer (EC) is the most common gynecologic cancer in the United States with ...
All CISOs use AI in 2026 survey, Pentera report shows, driving hybrid deterministic security validation models.
Retail Banker International on MSNOpinion
Validating AI-driven AML outcomes under FCA supervision
Dr Janet Bastiman discusses the future of AI for AML and offers expert guidance on how best to collaborate with the FCA and ...
Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results